Distribution of HIV infected individuals >15 years old, starting combination antiretroviral therapy, included in the national data warehouse sampling framework and randomly sampled, by COVID-19 exposure status in Kenya (April 2018 to March 2021, N = 7,046).

Distribution of HIV infected individuals >15 years old, starting combination antiretroviral therapy, included in the national data warehouse sampling framework and randomly sampled, by COVID-19 exposure status in Kenya (April 2018 to March 2021, N = 7,046).</p

Overall effect of the COVID-19 pandemic, defined as period after the first documented case when compared to the period prior to the pandemic, on initial virologic non-suppression (VnS) amongst HIV infected individuals aged >15 years using data from the national data warehouse sampling framework in Kenya (April 2018 to March 2021, N = 7,046).

Overall effect of the COVID-19 pandemic, defined as period after the first documented case when compared to the period prior to the pandemic, on initial virologic non-suppression (VnS) amongst HIV infected individuals aged >15 years using data from the national data warehouse sampling framework in Kenya (April 2018 to March 2021, N = 7,046).</p

Effect of the COVID-19 pandemic, defined as the period after the first documented case when compared to the period prior to the pandemic, on time from a HIV diagnosis to combination antiretroviral therapy start (Same-day HIV diagnosis and ART initiation) amongst HIV infected individuals aged >15 years using data from the national data warehouse sampling framework in Kenya (April 01^st 2018 to March 31^st 2021, N = 7,046)^b'*'.

Effect of the COVID-19 pandemic, defined as the period after the first documented case when compared to the period prior to the pandemic, on time from a HIV diagnosis to combination antiretroviral therapy start (Same-day HIV diagnosis and ART initiation) amongst HIV infected individuals aged >15 years using data from the national data warehouse sampling framework in Kenya (April 01st 2018 to March 31st 2021, N = 7,046)b'*'.</p

Fig 5 -

(a) Graph showing initial virologic non-suppression (viral load >1000 copies/ml) after ART initiation by COVID-19 exposure calendar period when compared to the period prior to the pandemic, and (b) by high infection zone counties, amongst HIV infected individuals >15 years using data from the national data warehouse sampling framework in Kenya (April 01st 2018 to March 31st 2021, N = 7,046).</p

Fig 4 -

(a) Graph showing six-months retention after ART initiation by COVID-19 exposure calendar period when compared to the period prior to the pandemic, and (b) by high infection zone counties, amongst HIV infected individuals >15 years using data from the national data warehouse sampling framework in Kenya (April 01st 2018 to March 31st 2021, N = 7,046).</p

Overall effect of the COVID-19 pandemic, defined as period after the first documented case when compared to the period prior to the pandemic, on time from a HIV diagnosis to combination antiretroviral therapy start (Same day ART initiation) amongst HIV infected individuals aged >15 years using data from the national data warehouse sampling framework in Kenya (April 2018 to March 2021, N = 7,046).

Overall effect of the COVID-19 pandemic, defined as period after the first documented case when compared to the period prior to the pandemic, on time from a HIV diagnosis to combination antiretroviral therapy start (Same day ART initiation) amongst HIV infected individuals aged >15 years using data from the national data warehouse sampling framework in Kenya (April 2018 to March 2021, N = 7,046).</p

Overall effect of the COVID-19 pandemic, defined as period after the first documented case when compared to the period prior to the pandemic, on attrition from combination antiretroviral therapy start amongst HIV infected individuals aged >15 years using data from the national data warehouse sampling framework in Kenya (April 2018 to March 2021, N = 7,046).

Overall effect of the COVID-19 pandemic, defined as period after the first documented case when compared to the period prior to the pandemic, on attrition from combination antiretroviral therapy start amongst HIV infected individuals aged >15 years using data from the national data warehouse sampling framework in Kenya (April 2018 to March 2021, N = 7,046).</p

A comparison of the general eligible and randomly sampled population of HIV infected individuals aged >15 years at the start of combination antiretroviral therapy using data from the national data warehouse (April 01^st 2018 to March 31^st 2021, N = 352,322).

A comparison of the general eligible and randomly sampled population of HIV infected individuals aged >15 years at the start of combination antiretroviral therapy using data from the national data warehouse (April 01st 2018 to March 31st 2021, N = 352,322).</p

Effect of the SARS-CoV-2 pandemic, defined as the period after the first documented case when compared to the period prior to the pandemic, on virologic non-suppression amongst HIV infected individuals >15 years starting combination antiretroviral therapy using data from the national data warehouse sampling framework in Kenya (April 01^st 2018 to March 31^st 2021, N = 7,406)^b'*'.

Effect of the SARS-CoV-2 pandemic, defined as the period after the first documented case when compared to the period prior to the pandemic, on virologic non-suppression amongst HIV infected individuals >15 years starting combination antiretroviral therapy using data from the national data warehouse sampling framework in Kenya (April 01st 2018 to March 31st 2021, N = 7,406)b'*'.</p

Flow chart showing distribution of HIV infected individuals starting combination antiretroviral therapy (ART) included in the national data warehouse (NDW) sampling framework and random selection of individuals included in the analysis.

Flow chart showing distribution of HIV infected individuals starting combination antiretroviral therapy (ART) included in the national data warehouse (NDW) sampling framework and random selection of individuals included in the analysis.</p